Doctors Note Logo

Published on: 10/22/2026

Why a Biologic Injection Is Timed Around Your Operation Date

Biologic injections are deliberately scheduled around surgery because these medications suppress parts of the immune system, which can raise infection risk and slow wound healing if a dose is active during the operation and early recovery. Surgeons and rheumatologists typically time the last pre-op dose so the procedure falls at the end of a dosing cycle, then restart once incisions show healthy healing and no signs of infection, with the exact timing depending on the drug's half-life, your condition, and the complexity of the surgery. Holding a biologic too long, however, can trigger a disease flare that makes rehabilitation harder, so the goal is a balance rather than a fixed rule. There are several important factors to consider, including drug-specific wait times and flare risk. See below to understand more.

If you are weighing surgery while on a biologic and noticing new symptoms such as fever, joint swelling, redness around a wound, or unusual fatigue, getting clarity quickly matters, because those details can change how your medication is timed. A free, instant, online symptom check can help you organize what you are experiencing, see which possible causes fit your pattern, and understand which questions to raise with your surgeon or rheumatologist before your next dose. It takes only a few minutes, requires no appointment, and gives you a clearer starting point for the conversation that shapes your surgical plan.

Last reviewed for medical accuracy: 10/22/2026

answer background

Concerned about your symptoms?

Explanation

Why a Biologic Injection Is Timed Around Your Operation Date

If you’re scheduled for surgery and already on biologic therapy, you may wonder why your doctor adjusts the timing of your injection. Biologic medications—often used for conditions like rheumatoid arthritis, Crohn’s disease or psoriasis—can affect how your body fights infection and heals wounds. Knowing the reasons behind timing changes can help you feel informed and confident as you prepare for your operation.

What Are Biologic Injections?

Biologic injections are advanced treatments made from living cells. They target specific parts of your immune system that drive inflammation. Common biologics include:

  • TNF-alpha inhibitors (e.g., infliximab, adalimumab, etanercept)
  • Interleukin blockers (e.g., ustekinumab, secukinumab)
  • Cell-depleting agents (e.g., rituximab)

These drugs can be life-changing by reducing pain, swelling and tissue damage. But because they dial down parts of your immune response, they can also influence how your body handles surgery.

Why Timing Matters

  1. Infection Risk
    Biologics reduce inflammation by suppressing immune activity. Around the time of surgery, you need your immune system fully alert to help fend off bacteria at the incision site.

  2. Wound Healing
    Healing involves a coordinated immune response. If key inflammatory signals are blocked, wounds may heal more slowly or develop complications.

  3. Disease Control
    Stopping a biologic too early before surgery can cause your underlying disease to flare up. Adequate disease control helps reduce pain and stress before and after your operation.

Balancing these factors—lowering infection risk without triggering a flare—is why your injection schedule is carefully planned.

Typical Timing Guidelines

Every patient and every biologic is different. Your surgeon and prescribing doctor will work together to create a personalized plan. But here are general steps routinely used:

Before Surgery

  • Hold the biologic for a set interval
    Most guidelines recommend skipping a dose or two before your operation. For example:

    • Infliximab (Remicade): stop 4–6 weeks before surgery
    • Adalimumab (Humira): stop 2–3 weeks before surgery
    • Etanercept (Enbrel): stop 1–2 weeks before surgery
  • Coordinate with half-life
    Each biologic stays in your body a certain amount of time (its half-life). Your doctor times the last dose so that most of the drug clears your system, lowering infection risk.

  • Monitor disease status
    If your symptoms worsen during the hold period, your team may adjust timing or use a short-term alternative (like low-dose steroids) to keep you comfortable.

During Surgery

  • Close monitoring for infection
    Surgical teams use sterile techniques and may give you antibiotics to further minimize infection risk.

  • Careful wound management
    Dressings and follow-up visits ensure your incision is healing properly. Speak up if you notice redness, swelling or drainage.

After Surgery

  • Wait for initial healing
    Most surgeons suggest resuming biologics only after the wound shows clear signs of healing—often 10–14 days post-op for minor surgeries, longer for major procedures.

  • Watch for complications
    If you develop fever, unusual pain or wound problems, your doctor may delay restarting the biologic until everything looks stable.

  • Gradual restart
    Once approved, your first post-op dose may be lower or given under closer supervision to ensure you tolerate it well.

Factors That Influence Timing

Several individual factors affect your biologic injection before surgery plan:

  • Type of surgery
    Major operations (e.g., joint replacements, bowel resections) carry higher infection and healing-delay risks than minor procedures (e.g., skin biopsies).

  • Overall health
    Other conditions like diabetes, obesity or smoking can also slow healing. Your doctors may recommend extra precautions if you have these risk factors.

  • Previous infection history
    If you’ve had surgical site infections in the past, teams will be extra cautious about when to hold and restart biologics.

  • Disease activity
    Active inflammation can increase surgical risk. Sometimes it’s safer to keep you on biologic therapy until just before surgery rather than stopping too early and facing a flare.

Questions to Ask Your Medical Team

  • “How many doses do I need to skip before surgery?”
  • “What warning signs of infection should I watch for after my operation?”
  • “When exactly can I resume my biologic injection after surgery?”
  • “Are there short-term alternatives to control my disease while I’m off my biologic?”
  • “Will I need extra antibiotics or other precautions?”

Having clear answers to these questions will ease your mind and help you plan your recovery.

Preparing for Surgery: Practical Tips

  • Confirm the exact date you need to skip your next biologic dose.
  • Keep a medication calendar or set phone reminders.
  • Arrange transport and home help for the first few days after surgery.
  • Follow all pre-op instructions: fasting rules, skin prep, and hygiene steps.
  • Use the free, online symptom check, using the doctor approved Ubie Symptom Checker to track any new or changing symptoms before and after your procedure.

Recovery and Follow-Up

  • Attend all post-op appointments to monitor wound healing.
  • Keep your surgical site clean and dry.
  • Report any fever above 100.4°F (38°C), redness, swelling or unusual drainage.
  • Maintain a balanced diet rich in protein, vitamins and minerals to support tissue repair.
  • Stay as active as your surgeon allows—gentle walking boosts circulation and healing.

Working Together for Your Best Outcome

Your surgical team, primary care doctor and specialist (e.g., rheumatologist or gastroenterologist) collaborate on timing your biologic injection before surgery. Never adjust your medication schedule without talking to them first.

Understanding the “why” behind the timing can:

  • Reduce your risk of infection
  • Support faster, safer wound healing
  • Keep your underlying condition under control

Always speak up about any concerns or changes in how you feel—early intervention makes a big difference.


If you notice any serious or life-threatening symptoms—such as heavy bleeding, severe pain, high fever or signs of deep infection—seek medical care right away. For non-urgent questions or to check your symptoms at home, consider using the free, online symptom check, using the doctor approved Ubie Symptom Checker.

And remember: every patient’s situation is unique. Speak to a doctor about your specific surgery plan and medication timing to ensure the safest possible outcome.

(References)

  • * Orii R, Sugawara Y, Hayashida M, Yamada Y, Kubota K, Takayama T, Harihara Y, Makuuchi M, Hanaoka K. Peri-operative blood lactate levels in recipients of living-related liver transplantation. Transplantation. 2000 May 27;69(10):2124-7. doi: 10.1097/00007890-200005270-00028. PMID: 10852610.

  • * Prelog M, Zimmerhackl LB. Varicella vaccination in pediatric kidney and liver transplantation. Pediatr Transplant. 2010 Feb;14(1):41-7. doi: 10.1111/j.1399-3046.2009.01204.x. PMID: 20091941.

  • * Lin YH, Cai ZS, Jiang Y, Lü LZ, Zhang XJ, Cai QC. Perioperative risk factors for pulmonary complications after liver transplantation. J Int Med Res. 2010 Sep-Oct;38(5):1845-55. doi: 10.1177/147323001003800532. PMID: 21309501.

  • * Ponnusamy KE, Kim TJ, Khanuja HS. Perioperative blood transfusions in orthopaedic surgery. J Bone Joint Surg Am. 2014 Nov 5;96(21):1836-44. doi: 10.2106/JBJS.N.00128. PMID: 25378512.

  • * Li XX, Meng J, Sun GP, Tang YX, Liang GF, Wang MF, Lu XB. Effects of perioperative blood transfusion on the prognosis in hereditary and sporadic colon cancer. Biomarkers. 2015;20(6-7):481-6. doi: 10.3109/1354750X.2015.1096306. PMID: 26616149.

  • * Cisneros LG, Atoun E, Abraham R, Tsvieli O, Bruguera J, Levy O. Revision shoulder arthroplasty: does the stem really matter? J Shoulder Elbow Surg. 2016 May;25(5):747-55. doi: 10.1016/j.jse.2015.10.007. Epub 2016 Jan 25. PMID: 26821560.

  • * Wang T, Wang D, Yu H, Feng B, Zhou F, Zhang H, Zhou L, Jiao S, Li Y. A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors. Nat Commun. 2018 Apr 18;9(1):1532. doi: 10.1038/s41467-018-03915-4. Epub 2018 Apr 18. PMID: 29670088; PMCID: PMC5906566.

  • * Kanellopoulou T, Kostelidou T. Literature review of apheresis procedures performed perioperatively in cardiac surgery for ASFA category indications. J Clin Apher. 2019 Aug;34(4):474-479. doi: 10.1002/jca.21676. Epub 2018 Dec 8. PMID: 30537420.

  • * Wu Y, Wu Y, Gangoli G, Bourcet A, Danker W 3rd, Gong Q, Zhan H, Chen W, Wang Z. Using flowable gelatin in anterior cervical spine surgery in real-world practice: a retrospective cohort study. J Comp Eff Res. 2019 Apr;8(5):317-326. doi: 10.2217/cer-2018-0121. Epub 2019 Jan 25. PMID: 30681001.

  • * Tran TB, Maker VK, Maker AV. Impact of Immunotherapy after Resection of Pancreatic Cancer. J Am Coll Surg. 2019 Jul;229(1):19-27.e1. doi: 10.1016/j.jamcollsurg.2019.01.016. Epub 2019 Feb 10. PMID: 30742911; PMCID: PMC6599571.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.